協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/10/21 | 3,340 | 3,370 | 3,325 | 3,345 | -15 | -0.4% | 551,400 |
| 2022/10/20 | 3,335 | 3,380 | 3,330 | 3,360 | -20 | -0.6% | 589,600 |
| 2022/10/19 | 3,425 | 3,430 | 3,380 | 3,380 | -30 | -0.9% | 550,300 |
| 2022/10/18 | 3,415 | 3,425 | 3,375 | 3,410 | +50 | +1.5% | 655,500 |
| 2022/10/17 | 3,365 | 3,390 | 3,350 | 3,360 | -50 | -1.5% | 474,600 |
| 2022/10/14 | 3,355 | 3,415 | 3,345 | 3,410 | +85 | +2.6% | 982,100 |
| 2022/10/13 | 3,335 | 3,360 | 3,310 | 3,325 | -10 | -0.3% | 472,900 |
| 2022/10/12 | 3,340 | 3,375 | 3,325 | 3,335 | ±0 | ±0% | 585,500 |
| 2022/10/11 | 3,355 | 3,395 | 3,325 | 3,335 | -60 | -1.8% | 826,600 |
| 2022/10/07 | 3,380 | 3,400 | 3,310 | 3,395 | -15 | -0.4% | 620,300 |
| 2022/10/06 | 3,420 | 3,430 | 3,390 | 3,410 | -5 | -0.1% | 646,300 |
| 2022/10/05 | 3,430 | 3,455 | 3,380 | 3,415 | +20 | +0.6% | 1,035,100 |
| 2022/10/04 | 3,330 | 3,395 | 3,320 | 3,395 | +65 | +2% | 885,000 |
| 2022/10/03 | 3,265 | 3,330 | 3,225 | 3,330 | +15 | +0.5% | 1,066,400 |
| 2022/09/30 | 3,310 | 3,345 | 3,300 | 3,315 | +45 | +1.4% | 1,752,600 |
| 2022/09/29 | 3,210 | 3,270 | 3,200 | 3,270 | +105 | +3.3% | 950,900 |
| 2022/09/28 | 3,125 | 3,165 | 3,120 | 3,165 | +10 | +0.3% | 853,600 |
| 2022/09/27 | 3,120 | 3,170 | 3,120 | 3,155 | +30 | +1% | 634,800 |
| 2022/09/26 | 3,135 | 3,170 | 3,120 | 3,125 | -25 | -0.8% | 714,300 |
| 2022/09/22 | 3,190 | 3,190 | 3,145 | 3,150 | -40 | -1.3% | 614,900 |
| 2022/09/21 | 3,185 | 3,200 | 3,155 | 3,190 | ±0 | ±0% | 618,800 |
| 2022/09/20 | 3,235 | 3,245 | 3,155 | 3,190 | -60 | -1.8% | 701,800 |
| 2022/09/16 | 3,200 | 3,250 | 3,185 | 3,250 | +40 | +1.2% | 980,900 |
| 2022/09/15 | 3,220 | 3,230 | 3,190 | 3,210 | -5 | -0.2% | 435,700 |
| 2022/09/14 | 3,240 | 3,255 | 3,210 | 3,215 | -65 | -2% | 785,200 |
| 2022/09/13 | 3,300 | 3,325 | 3,265 | 3,280 | -20 | -0.6% | 617,300 |
| 2022/09/12 | 3,290 | 3,310 | 3,280 | 3,300 | +40 | +1.2% | 589,100 |
| 2022/09/09 | 3,225 | 3,275 | 3,215 | 3,260 | +45 | +1.4% | 1,181,200 |
| 2022/09/08 | 3,155 | 3,215 | 3,145 | 3,215 | +110 | +3.5% | 1,086,900 |
| 2022/09/07 | 3,085 | 3,115 | 3,065 | 3,105 | +10 | +0.3% | 887,500 |
| 2022/09/06 | 3,110 | 3,130 | 3,075 | 3,095 | ±0 | ±0% | 502,500 |
| 2022/09/05 | 3,100 | 3,110 | 3,085 | 3,095 | -35 | -1.1% | 586,300 |
| 2022/09/02 | 3,140 | 3,180 | 3,120 | 3,130 | +20 | +0.6% | 730,700 |
| 2022/09/01 | 3,105 | 3,125 | 3,080 | 3,110 | -25 | -0.8% | 751,100 |
| 2022/08/31 | 3,080 | 3,135 | 3,065 | 3,135 | +45 | +1.5% | 1,794,400 |
| 2022/08/30 | 3,075 | 3,115 | 3,065 | 3,090 | +25 | +0.8% | 600,800 |
| 2022/08/29 | 3,045 | 3,075 | 3,030 | 3,065 | -65 | -2.1% | 850,900 |
| 2022/08/26 | 3,130 | 3,155 | 3,110 | 3,130 | -5 | -0.2% | 583,000 |
| 2022/08/25 | 3,105 | 3,150 | 3,095 | 3,135 | +55 | +1.8% | 557,800 |
| 2022/08/24 | 3,085 | 3,100 | 3,060 | 3,080 | +10 | +0.3% | 603,800 |
| 2022/08/23 | 3,095 | 3,095 | 3,045 | 3,070 | -35 | -1.1% | 1,083,100 |
| 2022/08/22 | 3,065 | 3,115 | 3,035 | 3,105 | +15 | +0.5% | 841,300 |
| 2022/08/19 | 3,125 | 3,135 | 3,080 | 3,090 | -50 | -1.6% | 1,002,000 |
| 2022/08/18 | 3,170 | 3,190 | 3,125 | 3,140 | -60 | -1.9% | 552,500 |
| 2022/08/17 | 3,160 | 3,205 | 3,160 | 3,200 | +15 | +0.5% | 813,800 |
| 2022/08/16 | 3,235 | 3,235 | 3,170 | 3,185 | -30 | -0.9% | 510,000 |
| 2022/08/15 | 3,215 | 3,220 | 3,190 | 3,215 | +30 | +0.9% | 322,400 |
| 2022/08/12 | 3,210 | 3,215 | 3,160 | 3,185 | +65 | +2.1% | 1,296,900 |
| 2022/08/10 | 3,150 | 3,165 | 3,110 | 3,120 | -45 | -1.4% | 560,200 |
| 2022/08/09 | 3,160 | 3,200 | 3,145 | 3,165 | +15 | +0.5% | 728,200 |
601～
650
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 220,400円 | -3.5% | -11.3% | 2.72% | 20.24倍 | 1.36倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 139,000円 | +18.5% | -96.0% | 5.32% | 177.75倍 | 1.63倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 233,400円 | +5.7% | +3.9% | 2.46% | 11.61倍 | 1.54倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 394,200円 | +1.7% | -2.9% | 4.06% | 25.86倍 | 1.36倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 162,800円 | -3.5% | -50.2% | 4.91% | 13.19倍 | 0.98倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
